These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes. Moley JF, Brother MB, Fong CT, White PS, Baylin SB, Nelkin B, Wells SA, Brodeur GM. Cancer Res; 1992 Feb 15; 52(4):770-4. PubMed ID: 1346584 [Abstract] [Full Text] [Related]
10. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome. D'Adda T, Keller G, Bordi C, Höfler H. Lab Invest; 1999 Jun 15; 79(6):671-7. PubMed ID: 10378509 [Abstract] [Full Text] [Related]
11. Distinct target regions for chromosome 1p deletions in parathyroid adenomas and carcinomas. Välimäki S, Forsberg L, Farnebo LO, Larsson C. Int J Oncol; 2002 Oct 15; 21(4):727-35. PubMed ID: 12239610 [Abstract] [Full Text] [Related]
12. Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients. Lubensky IA, Debelenko LV, Zhuang Z, Emmert-Buck MR, Dong Q, Chandrasekharappa S, Guru SC, Manickam P, Olufemi SE, Marx SJ, Spiegel AM, Collins FS, Liotta LA. Cancer Res; 1996 Nov 15; 56(22):5272-8. PubMed ID: 8912868 [Abstract] [Full Text] [Related]
19. Cytogenetic and molecular analyses of multiple endocrine neoplasias of the MEN1 syndrome. Pourani J, Kaserer K, Pfragner R. Int J Oncol; 2002 May 15; 20(5):971-6. PubMed ID: 11956591 [Abstract] [Full Text] [Related]